查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1483674

神经血管血栓切除设备市场 - 全球规模、份额、趋势分析、机会、预测报告，2019-2030

Neurovascular Thrombectomy Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Device Type; By Indication; By End User; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

神经血管取栓设备的全球市场规模预计将以 6.88% 的复合年增长率大幅扩张，到 2030 年将达到 40.8 亿美元

由于人们对中风治疗和管理的认识不断提高、中风盛行率不断上升以及对改进诊断的日益关注，神经血管血栓切除设备的全球市场正在蓬勃发展。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计，2023 年全球神经血管血栓切除设备市场规模为 21.7 亿美元。 BlueWeave 预测，在 2024 年至 2030 年的预测期内，全球神经血管血栓切除设备市场规模将以 6.88% 的复合年增长率成长，到 2030 年将达到 40.8 亿美元。神经血管疾病的盛行率不断上升以及对有效治疗方案的需求不断增长是全球神经血管血栓切除设备市场成长的主要驱动力。此外，在分析期间，由于介入神经学领域研发活动的扩展，预计市场将发现利润丰厚的机会。

机会 - 增加获得医疗设施的机会

神经血管血栓切除设备的全球市场依最终用户分为医院、门诊手术中心、专科诊所等。医院细分市场占据最大的市场占有率，主要是由于大量的新生血管疾病患者到医院就各种病症进行诊断和治疗。特别是在印度和中国等新兴国家，由于医疗基础设施的成长，医院数量不断增加，预计在分析期间将推动全球神经血管血栓切除设备市场的医院领域。

地缘政治紧张局势加剧对神经血管血栓切除设备全球市场的影响

地缘政治紧张局势的加剧阻碍了全球神经血管血栓切除设备市场的成长。 2022年2月开始的俄乌战争突然给乌克兰卫生部门带来了巨大压力，造成了前所未有的困难。炸弹摧毁了建筑物并扰乱了医疗服务的提供。缺乏医护人员的帮助阻碍了常规预防性检查，导致神经血管疾病的诊断率较低。巴勒斯坦的医疗机构也面临类似的情况，这直接影响了对神经血管血栓切除设备的需求，并限制了这些地区的市场成长。

神经血管血栓切除装置的全球市场

按细分市场分類的覆盖范围

神经血管血栓切除装置的全球市场—依适应症分类

根据适应症，全球神经血管血栓切除设备市场分为缺血性中风、出血性中风等。由于缺血性中风在全球范围内的高盛行率，其在全球神经血管血栓切除设备市场中占最高份额。根据世界中风组织的数据，缺血性中风占全球整体中风病例的62%以上。对先进神经血管血栓切除设备开发的日益关注和投资预计将为市场参与企业提供利润丰厚的成长机会。

神经血管血栓切除装置的全球市场 – 按地区

关于神经血管血栓切除装置全球市场的详细研究报告涵盖了五个主要地区的众多各国市场。北美、欧洲、亚太地区、拉丁美洲和中东非洲。北美主导全球神经血管血栓切除设备市场。神经血管疾病负担的增加、医疗保健支出的增加以及门诊医疗设施数量的增加直接影响北美市场的成长。此外，针对各种神经血管疾病的优惠报销政策也促进了北美神经血管血栓切除设备市场的成长。

竞争格局

在全球神经血管血栓切除设备市场中营运的主要企业包括Acandis GmbH、Penumbra, Inc.、Medtronic、VESALIO, LLC、Johnson &Johnson、MicroVention, Inc.、Phenox GmbH、Imperative Care, Inc.、Balt Group、NeuroVasc Technologies, Inc.。

为了进一步增加市场占有率，这些公司正在采取各种策略，例如併购、合作、合资、授权合约和新产品发布。

该报告的详细分析涵盖了全球神经血管血栓切除设备市场的成长潜力、未来趋势和资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球神经血管血栓切除设备市场的最新技术趋势以及产业见解，以帮助决策者做出明智的策略决策。此外，我们也分析市场成长动力、挑战和竞争对手。

目录

第一章 研究框架

第 2 章执行摘要

第三章全球神经血管血栓切除设备市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 中风发生率上升
      • 人口老化加剧
      • 提高认识并改善诊断
      • 优惠退款政策
    • 抑制因素
      • 设备高成本
      • 有限的医疗专业知识
      • 严格的监管要求
    • 机会
      • 技术进步
      • 新兴市场
      • 专注微创手术
    • 任务
      • 保持程序效率
      • 许多国家的报销挑战
      • 竞争加剧
  • 科技进步/最新发展
  • 法律规范
  • 波特五力分析

第四章全球神经血管血栓切除设备市场：行销策略

第五章全球神经血管血栓切除设备市场概述

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依设备类型
      • 吸引装置
      • 支架取出装置
      • 机械取栓装置
      • 吸引装置
      • 其他的
    • 按指示
      • 缺血性中风
      • 出血性中风
      • 其他的
    • 按最终用户
      • 医院
      • 门诊手术中心
      • 专科诊所
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲 (LATAM)
      • 中东/非洲

第六章北美神经血管血栓切除设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依设备类型
    • 按指示
    • 按最终用户
    • 按国家/地区
      • 美国
      • 加拿大

第七章欧洲神经血管血栓切除设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依设备类型
    • 按指示
    • 按最终用户
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 欧洲其他地区

第八章亚太神经血管血栓切除设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依设备类型
    • 按指示
    • 按最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 其他亚太地区

第九章拉丁美洲神经血管血栓切除设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依设备类型
    • 按指示
    • 按最终用户
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第十章中东与非洲神经血管血栓切除设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依设备类型
    • 按指示
    • 按最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 中东和非洲其他地区

第十一章竞争格局

  • 主要参与企业及其产品列表
  • 2023年全球神经血管血栓切除设备市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 重大策略发展（合併、收购、联盟等）

第十二章地缘政治紧张局势加剧对全球神经血管血栓切除设备市场的影响

第十三章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • Acandis GmbH
  • Penumbra, Inc.
  • Medtronic
  • VESALIO, LLC
  • Johnson and Johnson
  • MicroVention, Inc.
  • Phenox GmbH
  • Imperative Care, Inc.
  • Balt Group
  • NeuroVasc Technologies, Inc.
  • Baylis Medical Company, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Spectranetics Corporation
  • Edwards Lifesciences Corporation
  • Argon Medical Devices, Inc
  • Teleflex Incorporated
  • 其他主要企业

第十四章 主要策略建议

第十五章调查方法

简介目录
Product Code: BWC24305

Global Neurovascular Thrombectomy Devices Market Size Set to Expand at Significant CAGR of 6.88% to Reach USD 4.08 Billion by 2030

Global Neurovascular Thrombectomy Devices Market is flourishing because of growing awareness about the treatment and management of stroke, rising prevalence of stroke, and an increasing focus on improved diagnosis.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Neurovascular Thrombectomy Devices Market size at USD 2.17 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Neurovascular Thrombectomy Devices Market size to expand at a CAGR of 6.88% reaching a value of USD 4.08 billion by 2030. The growing incidence of neurovascular illnesses and the expanding need for efficient treatment options are key drivers of growth for the Global Neurovascular Thrombectomy Devices Market. Furthermore, during the period in analysis, the market is expected to witness lucrative opportunities due to the expansion of research and development activities in the field of interventional neurology.

Opportunity - Rising accessibility to healthcare facilities

The Global Neurovascular Thrombectomy Devices Market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others, based on end user. The hospitals segment holds the largest market share, mainly due to the high number of patients with neovascular diseases approaching hospitals for the diagnosis and treatment of various conditions. The increasing number of hospitals, particularly in emerging economies, such as India and China, owing to healthcare infrastructure growth, is anticipated to drive the hospital segment in the Global Neurovascular Thrombectomy Devices Market during the period in analysis.

Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market

The escalating geopolitical tensions hindered the growth of Global Neurovascular Thrombectomy Devices Market. The Russia-Ukraine war, began in February 2022, abruptly put the Ukraine's healthcare sector under tremendous strain and presented unprecedented difficulties. Bombs destroyed buildings and interfered with the delivery of healthcare services. Routine preventive checkups were hindered due to the inaccessibility of healthcare professionals, which resulted in a decline in the diagnosis rate of neurovascular diseases. In Palestine, healthcare facilities have been facing a similar situation, which directly impacts the demand for neurovascular thrombectomy devices, limiting its market growth in these regions.

Global Neurovascular Thrombectomy Devices Market

Segmental Coverage

Global Neurovascular Thrombectomy Devices Market - By Indication

Based on the indication, the Global Neurovascular Thrombectomy Devices Market is segmented into ischemic stroke, hemorrhagic stroke, and others. The ischemic stroke segment accounts for the highest share in the Global Neurovascular Thrombectomy Devices Market owing to its high prevalence worldwide. According to the World Stroke Organization, ischemic strokes account for more than 62% of all stroke incidents globally. The rising focus and investments to develop advanced neurovascular thrombectomy devices is expected to provide lucrative growth opportunities to the market players.

Global Neurovascular Thrombectomy Devices Market - By Region

The in-depth research report on the Global Neurovascular Thrombectomy Devices Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Neurovascular Thrombectomy Devices Market. The increasing burden of neurovascular diseases, rising expenditure in healthcare, and growth in ambulatory care facilities are directly influencing the growth of the market in North America. Furthermore, favorable reimbursement policies for various neurovascular conditions also contribute to the growth of the Neurovascular Thrombectomy Devices Market in North America.

Competitive Landscape

Major players operating in the Global Neurovascular Thrombectomy Devices Market include Acandis GmbH, Penumbra, Inc., Medtronic, VESALIO, LLC, Johnson & Johnson, MicroVention, Inc., Phenox GmbH, Imperative Care, Inc., Balt Group, NeuroVasc Technologies, Inc., Baylis Medical Company, Inc., Boston Scientific Corporation, Terumo Corporation, Spectranetics Corporation, Edwards Lifesciences Corporation, Argon Medical Devices, Inc., and Teleflex Incorporated.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Neurovascular Thrombectomy Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Neurovascular Thrombectomy Devices Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Neurovascular Thrombectomy Devices Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising Prevalence of Stroke
      • 3.2.1.2. Growing Geriatric Population
      • 3.2.1.3. Increasing Awareness and Improved Diagnosis
      • 3.2.1.4. Favorable Reimbursement Policies
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Devices
      • 3.2.2.2. Limited Medical Expertise
      • 3.2.2.3. Stringent Regulatory Requirements
    • 3.2.3. Opportunities
      • 3.2.3.1. Technological Advancements
      • 3.2.3.2. Emerging Markets
      • 3.2.3.3. Focus on Minimally Invasive Procedures
    • 3.2.4. Challenges
      • 3.2.4.1. Maintaining Procedural Efficiency
      • 3.2.4.2. Reimbursement Challenges in Many Countries
      • 3.2.4.3. Increased Competition
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Neurovascular Thrombectomy Devices Market: Marketing Strategies

5. Global Neurovascular Thrombectomy Devices Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Device Type
      • 5.2.1.1. Aspiration Devices
      • 5.2.1.2. Stent Retrievers
      • 5.2.1.3. Mechanical Embolus Removal Devices
      • 5.2.1.4. Suction Devices
      • 5.2.1.5. Others
    • 5.2.2. By Indication
      • 5.2.2.1. Ischemic Stroke
      • 5.2.2.2. Hemorrhagic Stroke
      • 5.2.2.3. Others
    • 5.2.3. By End User
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Ambulatory Surgical Centers
      • 5.2.3.3. Specialty Clinics
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia Pacific (APAC)
      • 5.2.4.4. Latin America (LATAM)
      • 5.2.4.5. Middle East and Africa (MEA)

6. North America Neurovascular Thrombectomy Devices Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Indication
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.1.1. By Device Type
      • 6.2.4.1.2. By Indication
      • 6.2.4.1.3. By End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. By Device Type
      • 6.2.4.2.2. By Indication
      • 6.2.4.2.3. By End User

7. Europe Neurovascular Thrombectomy Devices Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Indication
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.1.1. By Device Type
      • 7.2.4.1.2. By Indication
      • 7.2.4.1.3. By End User
      • 7.2.4.2. United Kingdom
      • 7.2.4.2.1. By Device Type
      • 7.2.4.2.2. By Indication
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Italy
      • 7.2.4.3.1. By Device Type
      • 7.2.4.3.2. By Indication
      • 7.2.4.3.3. By End User
      • 7.2.4.4. France
      • 7.2.4.4.1. By Device Type
      • 7.2.4.4.2. By Indication
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Spain
      • 7.2.4.5.1. By Device Type
      • 7.2.4.5.2. By Indication
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Belgium
      • 7.2.4.6.1. By Device Type
      • 7.2.4.6.2. By Indication
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Russia
      • 7.2.4.7.1. By Device Type
      • 7.2.4.7.2. By Indication
      • 7.2.4.7.3. By End User
      • 7.2.4.8. The Netherlands
      • 7.2.4.8.1. By Device Type
      • 7.2.4.8.2. By Indication
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Rest of Europe
      • 7.2.4.9.1. By Device Type
      • 7.2.4.9.2. By Indication
      • 7.2.4.9.3. By End User

8. Asia Pacific Neurovascular Thrombectomy Devices Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Indication
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.1.1. By Device Type
      • 8.2.4.1.2. By Indication
      • 8.2.4.1.3. By End User
      • 8.2.4.2. India
      • 8.2.4.2.1. By Device Type
      • 8.2.4.2.2. By Indication
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Japan
      • 8.2.4.3.1. By Device Type
      • 8.2.4.3.2. By Indication
      • 8.2.4.3.3. By End User
      • 8.2.4.4. South Korea
      • 8.2.4.4.1. By Device Type
      • 8.2.4.4.2. By Indication
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Australia & New Zealand
      • 8.2.4.5.1. By Device Type
      • 8.2.4.5.2. By Indication
      • 8.2.4.5.3. By End User
      • 8.2.4.6. Indonesia
      • 8.2.4.6.1. By Device Type
      • 8.2.4.6.2. By Indication
      • 8.2.4.6.3. By End User
      • 8.2.4.7. Malaysia
      • 8.2.4.7.1. By Device Type
      • 8.2.4.7.2. By Indication
      • 8.2.4.7.3. By End User
      • 8.2.4.8. Singapore
      • 8.2.4.8.1. By Device Type
      • 8.2.4.8.2. By Indication
      • 8.2.4.8.3. By End User
      • 8.2.4.9. Vietnam
      • 8.2.4.9.1. By Device Type
      • 8.2.4.9.2. By Indication
      • 8.2.4.9.3. By End User
      • 8.2.4.10. Rest of APAC
      • 8.2.4.10.1. By Device Type
      • 8.2.4.10.2. By Indication
      • 8.2.4.10.3. By End User

9. Latin America Neurovascular Thrombectomy Devices Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Indication
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.1.1. By Device Type
      • 9.2.4.1.2. By Indication
      • 9.2.4.1.3. By End User
      • 9.2.4.2. Mexico
      • 9.2.4.2.1. By Device Type
      • 9.2.4.2.2. By Indication
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Argentina
      • 9.2.4.3.1. By Device Type
      • 9.2.4.3.2. By Indication
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Peru
      • 9.2.4.4.1. By Device Type
      • 9.2.4.4.2. By Indication
      • 9.2.4.4.3. By End User
      • 9.2.4.5. Rest of LATAM
      • 9.2.4.5.1. By Device Type
      • 9.2.4.5.2. By Indication
      • 9.2.4.5.3. By End User

10. Middle East and Africa Neurovascular Thrombectomy Devices Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Indication
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.1.1. By Device Type
      • 10.2.4.1.2. By Indication
      • 10.2.4.1.3. By End User
      • 10.2.4.2. UAE
      • 10.2.4.2.1. By Device Type
      • 10.2.4.2.2. By Indication
      • 10.2.4.2.3. By End User
      • 10.2.4.3. Qatar
      • 10.2.4.3.1. By Device Type
      • 10.2.4.3.2. By Indication
      • 10.2.4.3.3. By End User
      • 10.2.4.4. Kuwait
      • 10.2.4.4.1. By Device Type
      • 10.2.4.4.2. By Indication
      • 10.2.4.4.3. By End User
      • 10.2.4.5. South Africa
      • 10.2.4.5.1. By Device Type
      • 10.2.4.5.2. By Indication
      • 10.2.4.5.3. By End User
      • 10.2.4.6. Nigeria
      • 10.2.4.6.1. By Device Type
      • 10.2.4.6.2. By Indication
      • 10.2.4.6.3. By End User
      • 10.2.4.7. Algeria
      • 10.2.4.7.1. By Device Type
      • 10.2.4.7.2. By Indication
      • 10.2.4.7.3. By End User
      • 10.2.4.8. Rest of MEA
      • 10.2.4.8.1. By Device Type
      • 10.2.4.8.2. By Indication
      • 10.2.4.8.3. By End User

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Neurovascular Thrombectomy Devices Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 13.1. Acandis GmbH
  • 13.2. Penumbra, Inc.
  • 13.3. Medtronic
  • 13.4. VESALIO, LLC
  • 13.5. Johnson and Johnson
  • 13.6. MicroVention, Inc.
  • 13.7. Phenox GmbH
  • 13.8. Imperative Care, Inc.
  • 13.9. Balt Group
  • 13.10. NeuroVasc Technologies, Inc.
  • 13.11. Baylis Medical Company, Inc.
  • 13.12. Boston Scientific Corporation
  • 13.13. Terumo Corporation
  • 13.14. Spectranetics Corporation
  • 13.15. Edwards Lifesciences Corporation
  • 13.16. Argon Medical Devices, Inc
  • 13.17. Teleflex Incorporated
  • 13.18. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations